Viking Therapeutics, Inc. short interest in 2020
In 2020, Viking Therapeutics, Inc.'s disclosed short interest ran from 22.72% of shares outstanding on 15 Jan 2020 to 12.44% on 31 Dec 2020, a change of -10.28 percentage points. The year's high was 22.96% on 28 Feb 2020 and its low 11.98% on 31 Aug 2020, averaging 16.23% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.07 days on 14 Feb 2020. Full history: Viking Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 22.72% (15 Jan 2020)
- End of year
- 12.44% (31 Dec 2020)
- Change
- -10.28 pp
- High
- 22.96% (28 Feb 2020)
- Low
- 11.98% (31 Aug 2020)
- Average
- 16.23%
- Highest days to cover
- 21.07 (14 Feb 2020)
- SEC filings marked
- 7
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 22.72% | 16.78 | |
| 31 Jan 2020 | 21.25% | 15.60 | |
| 14 Feb 2020 | 20.65% | 21.07 | |
| 28 Feb 2020 | 22.96% | 11.60 | 10-K filed |
| 13 Mar 2020 | 20.33% | 10.41 | |
| 31 Mar 2020 | 20.34% | 8.40 | |
| 15 Apr 2020 | 18.77% | 8.68 | |
| 30 Apr 2020 | 17.14% | 10.00 | 10-Q filed, results (8-K) |
| 15 May 2020 | 16.88% | 6.69 | |
| 29 May 2020 | 15.45% | 7.37 | |
| 15 Jun 2020 | 15.13% | 7.78 | |
| 30 Jun 2020 | 16.41% | 8.00 | |
| 15 Jul 2020 | 13.70% | 8.00 | |
| 31 Jul 2020 | 14.55% | 9.88 | 10-Q filed, results (8-K) |
| 14 Aug 2020 | 11.99% | 9.74 | |
| 31 Aug 2020 | 11.98% | 7.35 | |
| 15 Sep 2020 | 12.84% | 7.66 | |
| 30 Sep 2020 | 15.40% | 9.28 | |
| 15 Oct 2020 | 14.26% | 10.53 | |
| 30 Oct 2020 | 13.89% | 9.51 | 10-Q filed, results (8-K) |
| 13 Nov 2020 | 14.68% | 11.71 | |
| 30 Nov 2020 | 13.65% | 9.58 | |
| 15 Dec 2020 | 12.08% | 7.58 | |
| 31 Dec 2020 | 12.44% | 7.09 |
See also: Viking Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.